Loading clinical trials...
Loading clinical trials...
A Phase 1b Study of Oraxol in Combination With Ramucirumab in Patients With Gastric, Gastro-esophageal, or Esophageal Cancers
Conditions
Interventions
Oraxol
Ramucirumab
Locations
5
United States
CTRC-UT
San Antonio, Texas, United States
China Medical University Hospital
Taichung, Taiwan
Tri-Service General Hospital
Taipei, Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan
Lotung Poh-Ai Hospital
Yilan, Taiwan
Start Date
December 8, 2016
Primary Completion Date
March 27, 2019
Completion Date
December 31, 2022
Last Updated
February 16, 2022
NCT04704661
NCT04550494
NCT05489211
NCT05702229
NCT04674267
NCT07217704
Lead Sponsor
Athenex, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions